TC
CVS icon

Tacita Capital’s CVS Health CVS Stock Holding History

Tacita Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-793
Closed -$49.9K – 207
2024
Q3 		$49.9K Hold
793
– – 0.03% 147
2024
Q2 		$46.8K Buy
793
+158
+25% +$9.88K 0.03% 149
2024
Q1 		$50.6K Buy
+635
New +$48.5K 0.04% 152
2023
Q3 		– Sell
-765
Closed -$53K – 194
2023
Q2 		$53K Hold
765
– – 0.04% 137
2023
Q1 		$57K Buy
765
+200
+35% +$16.8K 0.04% 125
2022
Q4 		$53K Sell
565
-35
-6% -$3.38K 0.04% 125
2022
Q3 		$57K Hold
600
– – 0.04% 107
2022
Q2 		$56K Hold
600
– – 0.04% 122
2022
Q1 		$61K Hold
600
– – 0.04% 128
2021
Q4 		$62K Hold
600
– – 0.04% 125
2021
Q3 		$51K Sell
600
-150
-20% -$12.6K 0.03% 136
2021
Q2 		$63K Hold
750
– – 0.04% 121
2021
Q1 		$56K Sell
750
-1,327
-64% -$96.7K 0.04% 140
2020
Q4 		$142K Buy
+2,077
New +$135K 0.09% 93

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Tacita Capital's CVS Position: Q4 2024 in Review

Tacita Capital sold out of CVS Health (CVS) in Q4 2024, closing a stake of 793 shares — an estimated $49.9K sold.

Tacita Capital first reported a position in CVS in Q4 2020 and held it in 14 quarters. The position peaked at $142K in Q4 2020. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Tacita Capital reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Tacita Capital sold 793 CVS Health shares in Q4 2024, an estimated $49.9K.
  • Tacita Capital first reported a position in CVS Health in Q4 2020 and held it in 14 quarters.
  • Tacita Capital's CVS Health position peaked at $142K in Q4 2020.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Tacita Capital's 13F filing for Q4 2024, filed 6 Feb 2025.